XML 79 R7.htm IDEA: XBRL DOCUMENT v3.25.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:    
Net loss $ (7,607,182) $ (4,648,709)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock compensation 3,560,509 2,413,375
Depreciation 503
Amortization 15,107 3,751
Non-cash lease expense 496 5,675
Write off of inventory (0) 5,762
Gain on sale of short-term investments (130,110) (231,880)
Return on investment in Joint Venture 95,136
Extinguishment of debt - note payable (615,000)
Changes in operating assets and liabilities:    
Accounts receivable (880)
Accounts receivable - related party (3,674) (3,614)
Prepaid assets 22,073 (43,388)
Inventory (18,158) (7,812)
Accounts payable - related party (260,000)
Accounts payable (3,585) (238,833)
Accrued expenses (110,539) (163,538)
Accrued expenses - related party 240,000
Lease liability (4,463) (50,797)
Net cash (used in) provided by operating activities (3,944,390) (3,835,384)
Cash flows from investing activities:    
Sale of short-term investments 33,224,000 41,278,241
Purchase of short-term investments (33,631,233) (36,620,090)
Investment in Equity Method Investment (96,000)
Purchase of patents (116,812) (98,970)
Purchase of trademarks (53,494) (10,309)
Net cash (used in) provided by investing activities (577,539) 4,452,872
Cash flows from financing activities:    
Sale of common stock for cash, net of financing fees 4,516,184
Payments on notes payable - officer (200,000)
Net cash (used in) provided by financing activities 4,516,184 (200,000)
Net increase (decrease) in cash and cash equivalents (5,745) 417,487
Cash and cash equivalents - beginning of year 580,230 162,743
Cash and cash equivalents - end of year 574,485 580,230
Non-cash investing and financing activities:    
Unrealized loss on short-term investments $ (108) $ (36,718)